{
   "title": "Revenue of Johnson & Johnson 's pharmaceuticals segment worldwide 2012 to 2024",
   "labels": [
      "Year",
      "Immunology",
      "Cardiovascular/Metabolism/Other",
      "Oncology",
      "Central nervous system",
      "Anti-infectives"
   ],
   "columnType": "multi",
   "graphType": "line",
   "summaryType": "baseline",
   "summary": [
      "This line chart has 5 lines.",
      " The line representing Oncology had the highest values across Year with a mean value of 83.8.",
      " This peaked at 2019 with a value of 988.0. ",
      " The line with the second highest values was Immunology with a mean value of 10.8.",
      " This line peaked at 2019 with a value of 12.4"
   ],
   "trends": [
      {},
      {
         "2": [
            "0",
            "2"
         ],
         "16": [
            "12",
            "2"
         ]
      },
      {
         "1": [
            "7",
            "2"
         ],
         "9": [
            "7",
            "2"
         ]
      },
      {
         "2": [
            "0",
            "0"
         ],
         "15": [
            "12",
            "0"
         ]
      },
      {
         "1": [
            "7",
            "0"
         ],
         "10": [
            "7",
            "0"
         ]
      }
   ],
   "data": [
      {
         "Year": "2012",
         "Immunology": "7.87",
         "Cardiovascular/Metabolism/Other": "4.94",
         "Oncology": "2.63",
         "Central nervous system": "6.72",
         "Anti-infectives": "3.19"
      },
      {
         "Year": "2013",
         "Immunology": "9.19",
         "Cardiovascular/Metabolism/Other": "4.95",
         "Oncology": "3.77",
         "Central nervous system": "6.67",
         "Anti-infectives": "3.55"
      },
      {
         "Year": "2014",
         "Immunology": "10.19",
         "Cardiovascular/Metabolism/Other": "5.58",
         "Oncology": "4.46",
         "Central nervous system": "6.49",
         "Anti-infectives": "5.6"
      },
      {
         "Year": "2015",
         "Immunology": "10.4",
         "Cardiovascular/Metabolism/Other": "6.42",
         "Oncology": "4.7",
         "Central nervous system": "6.26",
         "Anti-infectives": "3.66"
      },
      {
         "Year": "2016",
         "Immunology": "11.97",
         "Cardiovascular/Metabolism/Other": "6.4",
         "Oncology": "5.81",
         "Central nervous system": "6.08",
         "Anti-infectives": "3.21"
      },
      {
         "Year": "2017",
         "Immunology": "12.24",
         "Cardiovascular/Metabolism/Other": "6.29",
         "Oncology": "7.26",
         "Central nervous system": "5.99",
         "Anti-infectives": "3.15"
      },
      {
         "Year": "2018",
         "Immunology": "12.34",
         "Cardiovascular/Metabolism/Other": "7.19",
         "Oncology": "8.96",
         "Central nervous system": "5.74",
         "Anti-infectives": "3.18"
      },
      {
         "Year": "2019",
         "Immunology": "12.49",
         "Cardiovascular/Metabolism/Other": "7.27",
         "Oncology": "988.0",
         "Central nervous system": "4.93",
         "Anti-infectives": "3.79"
      },
      {
         "Year": "2020",
         "Immunology": "12.09",
         "Cardiovascular/Metabolism/Other": "7.1",
         "Oncology": "10.73",
         "Central nervous system": "4.84",
         "Anti-infectives": "3.95"
      },
      {
         "Year": "2021",
         "Immunology": "11.69",
         "Cardiovascular/Metabolism/Other": "7.09",
         "Oncology": "11.78",
         "Central nervous system": "4.94",
         "Anti-infectives": "4.38"
      },
      {
         "Year": "2022",
         "Immunology": "11.14",
         "Cardiovascular/Metabolism/Other": "6.93",
         "Oncology": "12.71",
         "Central nervous system": "5.05",
         "Anti-infectives": "5.02"
      },
      {
         "Year": "2023",
         "Immunology": "10.24",
         "Cardiovascular/Metabolism/Other": "6.8",
         "Oncology": "13.91",
         "Central nervous system": "4.68",
         "Anti-infectives": "5.45"
      },
      {
         "Year": "2024",
         "Immunology": "9.34",
         "Cardiovascular/Metabolism/Other": "6.79",
         "Oncology": "14.86",
         "Central nervous system": "5.03",
         "Anti-infectives": "5.94"
      }
   ],
   "gold": "This statistic shows the revenue share of Johnson & Johnson 's pharmaceuticals segment worldwide from 2012 to 2024 , by product category . Johnson & Johnson is a multi-national company , specialized on pharmaceuticals , medical devices and consumer goods . The company is headquartered in New Brunswick , New Jersey .\n"
}